HGH Fragment 176-191 - Hilma Biocare

Growth Hormone Peptide Fragment 176-191, first described in 1976 by Bornstein. It is a truncated variant of human growth hormone (hGH) containing the last 16 amino acids. This fragment retains the fat reducing (lipolytic) properties of the full growth hormone but lacks its anabolic effects. It does not raise IGF-1 levels or bind to growth hormone receptors, making it a tool for fat loss in the fitness community.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about HGH Fragment 176-191 by Hilma Biocare, consult with your doctor or healthcare professional.